KING THOMAS BRAXTON
Insider CIK 1279309 · ALXA President and CEO, Director · STSA Director · TFFP Director · VVUS Interim Chief Executive Office, Director · ACHV Executive Chairman, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2025-09-04 | 2025-09-08 | 455,000 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2025-09-04 | 2025-09-08 | 455,000 | — | $0 | 455,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | S Sale | 2025-09-04 | 2025-09-08 | 139,858 | $2.77 | $387.4K | 315,142 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2025-06-06 | 2025-06-10 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2025-01-13 | 2025-01-14 | 195,000 | — | $0 | 195,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2025-01-13 | 2025-01-14 | 455,000 | — | $0 | 455,000 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2024-07-03 | 2024-07-08 | 1,583 | — | $0 | 1,583 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award | 2024-07-03 | 2024-07-08 | 1,583 | — | $0 | 1,583 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2024-04-18 | 2024-04-22 | 3,110 | — | $0 | 3,110 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2024-01-22 | 2024-01-24 | 31,500 | — | $0 | 31,500 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2023-12-13 | 2023-12-15 | 132,442 | — | $0 | 132,442 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 10,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 14,893 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 12,765 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 12,765 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2023-03-29 | 2023-06-09 | 23,250 | — | $0 | 23,250 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2023-03-29 | 2023-03-30 | 24,000 | — | $0 | 24,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2020-02-20 | 2020-02-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2018-10-26 | 2018-10-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2018-06-15 | 2018-06-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2018-01-26 | 2018-01-30 | 600,000 | — | $0 | 600,000 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2017-07-27 | 2017-07-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 50,001 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 50,000 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 400,000 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 5,819 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 5,453 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 9,921 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 19,576 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 33,449 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | U Tender | 2016-06-21 | 2016-06-21 | 40,000 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | U Tender | 2016-06-21 | 2016-06-21 | 37,224 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2015-07-22 | 2015-07-24 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2014-06-27 | 2014-06-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | P Buy | 2013-07-26 | 2013-07-26 | 2,420 | $4.49 | $10.9K | 215,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | P Buy | 2013-07-26 | 2013-07-30 | 2,420 | $4.49 | $10.9K | 215,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | P Buy | 2013-07-25 | 2013-07-26 | 12,580 | $4.50 | $56.6K | 212,580 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | P Buy | 2013-07-25 | 2013-07-30 | 12,580 | $4.50 | $56.6K | 212,580 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | P Buy | 2013-07-24 | 2013-07-26 | 25,000 | $4.48 | $112.0K | 200,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | P Buy | 2013-07-24 | 2013-07-30 | 25,000 | $4.48 | $112.0K | 200,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2013-03-29 | 2013-04-02 | 350,000 | — | $0 | 350,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award | 2013-03-29 | 2013-04-02 | 175,000 | $4.42 | $773.5K | 175,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | G Gift | 2013-02-25 | 2013-02-27 | 9,113 | — | $0 | 30,149 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | G Gift | 2013-02-25 | 2013-02-27 | 9,113 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | S Sale | 2012-08-27 | 2012-08-29 | 10,000 | $4.14 | $41.4K | 10,229 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | G Gift | 2012-08-14 | 2012-08-29 | 1,116 | — | $0 | 9,113 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | G Gift | 2012-08-14 | 2012-08-29 | 1,116 | — | $0 | 20,482 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2012-07-26 | 2012-07-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | S Sale | 2012-06-06 | 2012-06-08 | 65,516 | $0.34 | $22.3K | 202,325 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award | 2012-05-10 | 2012-05-14 | 100,000 | — | $0 | 267,841 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award | 2012-03-23 | 2012-03-26 | 65,516 | — | $0 | 167,841 | SEC↗ |